These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Gharavi AE; Harris EN; Asherson RA; Hughes GR Ann Rheum Dis; 1987 Jan; 46(1):1-6. PubMed ID: 3813670 [TBL] [Abstract][Full Text] [Related]
5. [Antiphospholipid antibodies and the risk of thrombosis: a comparative survey between chronic immune thrombocytopenia and primary antiphospholipid syndrome]. Moulis G; Delavigne K; Huguet F; Fortenfant F; Beyne-Rauzy O; Adoue D Rev Med Interne; 2011 Dec; 32(12):724-9. PubMed ID: 21864953 [TBL] [Abstract][Full Text] [Related]
6. Thrombotic Risk of Non-Criteria Anti-Phospholipid Antibodies Measured by Line Immunoassay: Superiority of Anti-Phosphatidylserine and Anti-Phosphatidic Acid Antibodies. Park HS; Gu JY; Jung HS; Kim HK Clin Lab; 2019 Mar; 65(3):. PubMed ID: 30868842 [TBL] [Abstract][Full Text] [Related]
7. Antibodies to anionic phospholipids and anti-beta2-GPI: association with thrombosis and thrombocytopenia in systemic lupus erythematosus. Amoroso A; Mitterhofer AP; Del Porto F; Garzia P; Ferri GM; Galluzzo S; Vadacca M; Caccavo D; Afeltra A Hum Immunol; 2003 Feb; 64(2):265-73. PubMed ID: 12559629 [TBL] [Abstract][Full Text] [Related]
8. Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients. López-Soto A; Cervera R; Font J; Bové A; Reverter JC; Muñoz FJ; Miret C; Espinosa G; Ordinas A; Ingelmo M Clin Exp Rheumatol; 1997; 15(2):143-9. PubMed ID: 9196865 [TBL] [Abstract][Full Text] [Related]
9. [Phospholipid antibodies (lupus anticoagulant and cardiolipin antibodies). Detection and clinical significance]. Wisløff F; Sletnes KE; Schjetlein R Tidsskr Nor Laegeforen; 1993 Aug; 113(18):2269-72. PubMed ID: 8362396 [TBL] [Abstract][Full Text] [Related]
10. Reactivity patterns of human anticardiolipin and other antiphospholipid antibodies in syphilitic sera. Costello PB; Green FA Infect Immun; 1986 Mar; 51(3):771-5. PubMed ID: 3512434 [TBL] [Abstract][Full Text] [Related]
11. Antiphospholipid antibodies in paediatric systemic lupus erythematosus, juvenile chronic arthritis and overlap syndromes: SLE patients with both lupus anticoagulant and high-titre anticardiolipin antibodies are at risk for clinical manifestations related to the antiphospholipid syndrome. Gattorno M; Buoncompagni A; Molinari AC; Barbano GC; Morreale G; Stalla F; Picco P; Mori PG; Pistoia V Br J Rheumatol; 1995 Sep; 34(9):873-81. PubMed ID: 7582730 [TBL] [Abstract][Full Text] [Related]
12. High prevalence of anticardiolipin antibodies in hepatitis C virus infection: lack of effects on thrombocytopenia and thrombotic complications. Harada M; Fujisawa Y; Sakisaka S; Kawaguchi T; Taniguchi E; Sakamoto M; Sumie S; Sasatomi K; Koga H; Torimura T; Ueno T; Gondo K; Yoshida H; Tanikawa K; Sata M J Gastroenterol; 2000; 35(4):272-7. PubMed ID: 10777156 [TBL] [Abstract][Full Text] [Related]
19. Anti-phospholipid antibodies bind to platelet microparticles in idiopathic (autoimmune) thrombocytopenic purpura. Nomura S; Yanabu M; Fukuroi T; Kido H; Kawakatsu T; Yamaguchi K; Suzuki M; Kokawa T; Yasunaga K Ann Hematol; 1992 Jul; 65(1):46-9. PubMed ID: 1643160 [TBL] [Abstract][Full Text] [Related]
20. Characteristics of the clinical findings in patients with idiopathic thrombocytopenic purpura who are positive for anti-phospholipid antibodies. Funauchi M; Hamada K; Enomoto H; Ikoma S; Ohno M; Kinoshita K; Horiuchi A Intern Med; 1997 Dec; 36(12):882-5. PubMed ID: 9475243 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]